|
- EOHILIA™ (budesonide oral suspension) Website for U. S. Residents
EOHILIA™ (budesonide oral suspension) is an FDA approved 12-week oral treatment for EoE in people 11 years and older It has not been shown to be safe and effective for longer than 12 weeks Website for U S residents only See Important Safety Information and Prescribing Information
- About EOHILIA™ (budesonide oral suspension) - How it Works How to Take It
EOHILIA is the first and only 12-week, FDA-approved oral treatment designed for people with eosinophilic esophagitis (EoE) 11 years and older It is a liquid-like form of budesonide specifically formulated to treat inflammation in the esophagus While the exact way budesonide works on EoE inflammation is not known, EOHILIA works on a wide range of inflammatory cells
- What to expect while taking EOHILIA
What is EOHILIA? EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older
- Clinical Results Safety Profile - EOHILIA™
Discover the clinical results and safety profile for EOHILIA™ (budesonide oral suspension) to treat eosinophilic esophagitis (EoE) in patients 11 years and older It has not been shown to be safe and effective for longer than 12 weeks See Important Safety Information and Prescribing Information
- What is EoE? | Symptoms, Causes, Treatment More - EOHILIA™
What is EOHILIA? EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid used for 12 weeks to treat Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for more than 12 weeks, or in children under 11 years
- Getting Started | EOHILIA™ (budesonide oral suspension)
Get started on EOHILIA™ (budesonide oral suspension) Talk to your doctor, manage costs with support programs, and find specialists See Important Safety Information and Prescribing Information
- Resources FAQs | EOHILIA™ (budesonide oral suspension)
Patient resources for EOHILIA™ (budesonide oral suspension) including a starter kit, downloadable guides, FAQs, and a glossary For U S residents only See Important Safety Information and Prescribing Information
- Patient Support Copay Card Program - EOHILIA™
The EOHILIA Patient Support and Copay Program The EOHILIA Patient Support and Copay Program is designed to help guide you along your EoE treatment journey Commercially insured patients prescribed EOHILIA™ may receive a one-time 30-day supply at no cost if access is not initially granted by their insurance provider
|
|
|